Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-23A Multi-Center, Open-Label Study to Evaluate Safety, Efficacy and Pharmacokinetics of Belimumab Plus Standard Therapy in Chinese Paediatric Patients With Active Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2025-07-22EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
-
CLINICAL_TRIALS study record update · 2025-07-20REACH (Restore Energy, Activity Can Help) Lupus Study
-
CLINICAL_TRIALS study record update · 2025-07-10Systemic Lupus Erythematosus in Gullah Health
-
CLINICAL_TRIALS study record update · 2025-07-02Efficacy of Synbiotic Supplementation on IL-10, TGF-B and Disease Activity in Systemic Lupus Erythematosus Patients; A Randomized, Double-Blind, Placebo-Controlled Trial
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-24A Randomized Controlled Phase I Clinical Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GNC-038 Tetra-specific Antibody Injection in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-06-10A Phase 2, Multicenter, Randomized, Double-blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Afimetoran in Participants With Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-06-10WEUKBRE6076: Belimumab (BENLYSTA) Pregnancy Registry Protocol
-
CLINICAL_TRIALS study record update · 2025-06-08Fatigue in Lupus Intervention Programmes (FLIP): A Randomised Controlled Trial Investigating the Effectiveness of Fatigue Management in Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-06-05A Prospective Cohort Study on Long-Term Outcomes in Patients With Systemic Lupus Erythematosus at Peking University People's Hospital
-
CLINICAL_TRIALS study record update · 2025-06-03A Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Preliminary Effectiveness of QLS4131 for Injection in Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-06-03A Phase I Study of BAFF CAR-T Cells (LMY-920) for Treatment of Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-06-03Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults. Optimization of Clinical Response, Remission, Quality of Life and Analysis of Prognostic Markers
-
CLINICAL_TRIALS study record update · 2025-05-25A Clinical Study of Anti-CD19 CAR-NK Cells in the Treatment of Refractory/Relapsed Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-05-23Transcutaneous Vagus Nerve Stimulation in SLE (TvSSLE)
-
CLINICAL_TRIALS study record update · 2025-05-18A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-05-14Efficacy and Safety of Belimumab for Prevention of Disease Flares in SLE Patients With Low Disease Activity
-
CLINICAL_TRIALS study record update · 2025-05-14A Single-Arm, Open-Label, Single-Center Investigator-Initiated Early-Stage Clinical Study for Relapsed/Refractory (R/R) Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-05-13ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
-
CLINICAL_TRIALS study record update · 2025-05-01A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapsed / Refractory Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-29A Phase Ib, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-25Study of BCMA/CD70 Targeted Chimeric Antigen Receptor T (CAR- T) Therapy for Refractory Childhood-oneset Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-24A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-24A Phase 1 Study to Evaluate the Safety and Preliminary Efficacy of ATA3219, Allogeneic Anti-CD19 Chimeric Antigen Receptor T-cell (CAR T) Therapy, in Subjects With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2025-04-17A Phase Ia Single Center, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Doses of HC022 in Healthy Subjects